Global Pneumatic Nebulizers Market Forecast From 2022 To 2032

Posted by sandeep gade on December 20th, 2022

 The Pneumatic Nebulizers market was valued at around US$ 726.9 Mn in 2021. With a projected CAGR of 7.1% for the next ten years, the market is likely to reach a valuation of nearly US$ 1.5 Bn by the end of 2032. The market is expected to register an absolute dollar opportunity of 760 Mn during the forecast period. The increasing number of cases of asthma, and COPD over the years have been advantageous for the demand for Pneumatic Nebulizers.

Competitive Analysis

Koninklijke Philips NV, Omron Corporation, General Electric, Medline Industries Inc., BD (Becton, Dickinson & Company), Allied Healthcare Products, Philips Respironics Inc., Briggs Healthcare, Heyer Medical AG, Medtronic PLC, PARI Pharma GmbH, Airssential Health Care , Vectura Group Plc., DeVilbiss Healthcare, Flexicare Medical Ltd., and, Clement Clarke International are among the key players worldwide driving the competitive landscape of the market. To expand their product portfolio and simultaneously capitalize on the growing market demand, many of these companies are adopting strategies such as mergers, acquisitions, and partnerships.

Some of the key recent developments in the pneumatic nebulizers market include:

In June 2021, Vectura Group Plc completed a buy-out of Skeypharma Production SAS, an oral manufacturing subsidiary based in Lyon, France. This announcement highlights the 2019 aim of the Vectura Group in order to become a completely inhalation focussed CDMO. This decision is set to positively impact Vectura Group Plc. during the upcoming forecast period.

In March 2021 , the authorization of PARI Pharma GmbH's LAMIRA Nebulizer System in Japan was announced. The nebulizing system has been announced to deliver ARIKAYCE (amikacin liposome inhalation suspension) developed by Insmed.

In January 2020, a new Automation Center in Tokyo was announced by OMRON Corporation, in order to enable customers to be included with the company for finding solutions to any challenges that may arise during the manufacturing process.

Buy Full Report Now and Get Up to 20% Discount: https://www.persistencemarketresearch.com/checkout/33240

Top Reports:

Bladder Cancer Treatment Drugs

Biosimilars

Medical Marijuana

Like it? Share it!


sandeep gade

About the Author

sandeep gade
Joined: August 22nd, 2022
Articles Posted: 835

More by this author